Since our vivax malaria patients have higher sTNFRII concentrations (which correlate positively with parasitemia) and sTNFRII/TNF-α ratios than falciparum malaria patients, they have comparatively less free TNF-α available for interaction with cell surface receptors. The gene discussed is CD177; the disease is parasitic infectious disease.